Regeneron Pharmaceuticals Inc REGN
$959.41
+4.73%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (17 Buy · 8 Hold · 0 Sell)
- Average Price Target
- $903.36
- Implied Upside
- -5.8%
- Price Target Range
- $185.00 – $1175.00
- Analysts (12 mo)
- 25
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-02 | Leerink PartnersDavid Risinger |
Maintains | Market perform | $835 → $997 |
| 2026-11-02 | BernsteinJeffrey Walch |
Maintains | Market perform | $756 → $812 |
| 2026-11-02 | Morgan StanleyMatthew Harrison |
Maintains | Equal-weight | $779 → $855 |
| 2026-11-02 | Truist SecuritiesGregory Renza |
Maintains | Buy | $780 → $982 |
| 2026-11-02 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $810 → $913 |
| 2026-11-02 | GuggenheimYatin Suneja |
Maintains | Buy | $1030 → $1100 |
| 2026-11-02 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $750 → $925 |
| 2026-11-02 | Evercore ISI GroupCory Kasimov |
Maintains | Outperform | $900 → $1075 |
| 2026-11-02 | Canaccord GenuityJohn Newman |
Maintains | Buy | $922 → $1175 |
| 2026-11-02 | Cantor FitzgeraldCarter Gould |
Maintains | Overweight | $795 → $980 |
| 2026-11-02 | BairdBrian Skorney |
Maintains | Neutral | $761 → $875 |
| 2026-11-02 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $908 → $1030 |
| 2026-10-30 | JP MorganChris Schott |
Maintains | Overweight | $950 → $1050 |
| 2026-10-30 | CitigroupGeoff Meacham |
Maintains | Neutral | $740 → $825 |
| 2026-10-28 | Canaccord GenuityJohn Newman |
Maintains | Buy | $875 → $922 |
| 2026-10-21 | TD CowenTyler Van Buren |
Maintains | Buy | $960 → $980 |
| 2026-10-19 | Piper SandlerBiren Amin |
Maintains | Overweight | $854 → $865 |
| 2026-10-15 | UBSTrung Huynh |
Upgrades | Neutral → Buy | $660 → $978 |
| 2026-10-08 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $737 → $810 |
| 2026-10-07 | Truist SecuritiesGregory Renza |
Maintains | Buy | $772 → $780 |
| 2026-10-07 | Morgan StanleyMatthew Harrison |
Maintains | Equal-weight | $758 → $779 |
| 2026-10-06 | JP MorganChris Schott |
Maintains | Overweight | $900 → $950 |
| 2026-10-01 | JefferiesAkash Tewari |
Maintains | Buy | $870 → $930 |
| 2026-10-01 | Argus ResearchJasper Hellweg |
Upgrades | Hold → Buy | $850 |
| 2026-09-29 | RBC CapitalBrian Abrahams |
Reiterates | Sector perform | $737 |
| 2026-09-10 | HSBCRajesh Kumar |
Maintains | Buy | $800 → $920 |
| 2026-08-17 | Leerink PartnersDavid Risinger |
Maintains | Market perform | $641 → $824 |
| 2026-08-03 | CitigroupGeoff Meacham |
Maintains | Neutral | $700 → $740 |
| 2026-08-03 | GuggenheimBrad Canino |
Maintains | Buy | $1000 → $1030 |
| 2026-07-31 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $696 → $737 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $959.41
- Market Cap
- $94.76 billion
- 52-Week Range
- $541.00 – $991.73
- Average Volume
- 865K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.